Blockchain.com joins major crypto firms testing U.S. prediction market platforms

More from Onpode All episodes →

1. 

   14 Oct 2026 · 10 minNew

   A new 12-week randomized trial shows aerobic and strength exercise improves metabolic health and fat mass even without scale weight dropping

   A randomized controlled trial published in Frontiers in Public Health (August 2026, trending October 14, 2026) examined the effects of 12 weeks of supervised combined aerobic and resistance training on body composition and physical function in overweight or obese adults with multiple cardiometabolic risk factors.

2. 

   14 Oct 2026 · 9 minNew

   Why candidates ignore most voters — the math of winner-take-all state delegation

   The Electoral College is the constitutional mechanism for electing the U.S. president, comprising 538 electors and requiring 270 electoral votes to win. Forty-eight states and Washington D.C. allocate their electoral votes on a winner-take-all (WTA) basis: whichever candidate wins the statewide popular vote receives all of that state's electoral votes, regardless of the margin of victory.

3. 

   14 Oct 2026 · 10 minNew

   White House lays groundwork to deport refugees already settled in U.S. — with new Supreme Court opening

   The Trump administration has pursued a multi-pronged strategy to curtail refugee protections and expand deportation pathways for individuals previously granted humanitarian status in the United States. The most consequential recent development is the Supreme Court's June 25, 2026, ruling in cases including Mullin v. Doe and Trump v.

4. 

   14 Oct 2026 · 9 minNew

   The structural debate: whether beliefs move societies or whether societies generate beliefs

   The Industrial Revolution, which began in Great Britain around 1760 and spread to Europe and the United States by 1840, is a recurring test case for one of historiography's deepest tensions: whether ideas or material conditions are the primary driver of large-scale historical change.

5. 

   14 Oct 2026 · 11 minNew

   Scientists found an injection that reduces dangerous belly fat independent of overall weight — raising questions about what matters most

   On October 13, 2026, research findings on an investigational injection called CBL-514 were announced, drawing attention to a potential new approach to reducing visceral abdominal fat without producing major overall weight loss. The data were presented at the European Association for the Study of Diabetes (EASD) 2026 annual meeting, held in Milan, Italy, from September 28 to October 2, 2026.

6. 

   14 Oct 2026 · 9 minNew

   Trump tells Ohio rally: if Democrats win Congress and White House, GOP is finished

   At a campaign rally in Youngstown, Ohio, on October 12, 2026 (reported widely on October 13), President Donald Trump declared that he would be "the last Republican president" if Democrats win control of Congress in the November midterms and subsequently gain the White House.

7. 

   14 Oct 2026 · 12 minNew

   Writing didn't just record speech — it created new forms of authority and control

   Before the invention of writing, human knowledge was oral and diffuse, preserved in the memories of designated specialists — elders, priests, scribes, and messengers — whose recall was the sole repository for laws, genealogies, rituals, and economic obligations.

8. 

   14 Oct 2026 · 9 minNew

   Democratic midterm wins could intensify Wall Street and crypto firm scrutiny, reshaping regulatory risk

   With the 2026 U.S. midterm elections approaching in November, Democratic gains in Congress — potentially flipping one or both chambers — would meaningfully shift the regulatory environment for Wall Street banks, cryptocurrency firms, and prediction markets.

9. 

   14 Oct 2026 · 9 minNew

   Battle lines shift as Republicans pull back from competitive House races ahead of midterms

   As of October 14, 2026 — three weeks before the 2026 midterm elections — Republican outside groups are pulling advertising spending from a handful of battleground U.S. House districts, while Democrats are redirecting money toward races previously considered long shots.

10. 

    14 Oct 2026 · 9 minNew

    FDA just approved a new drug specifically for herpes simplex virus lesions in adults

    On October 9, 2026, the U.S. Food and Drug Administration approved Hovilpri (pritelivir) 100 mg oral tablets, developed by Asahi Kasei Therapeutics, Inc., for the treatment of mucocutaneous lesions caused by herpes simplex virus (HSV) infection in immunocompromised adults.